Missouri legislation · 2026 Regular Session
Missouri HB2643: Establishes the "Hope for Missouri Patients Act"
Status: In committee, May 7, 2026
What the bill says
To amend chapter 191, RSMo, by adding thereto seven new sections relating to access to individualized investigational treatment. Section A. Chapter 191, RSMo, is amended by adding thereto seven new sections, to be known as sections 191.455, 191.457, 191.459, 191.461, 191.463, 191.465, and 191.467, to read as follows: 191.455. 1. Sections 191.455 to 191.467 shall be known and may be cited as the "Hope for Missouri Patients Act". 2. As used in sections 191.455 to 191.467, unless the context otherwise requires, the following terms mean: (1) "Eligible facility", an institution that is operating un.
From the introduced text:
To amend chapter 191, RSMo, by adding thereto seven new sections relating to access to individualized investigational treatment. Section A. Chapter 191, RSMo, is amended by adding thereto seven new sections, to be known as sections 191.455, 191.457, 191.459, 191.461, 191.463, 191.465, and 191.467, to read as follows: 191.455. 1. Sections 191.455 to 191.467 shall be known and may be cited as the "Hope for Missouri Patients Act". 2. As used in sections 191.455 to 191.467, unless the context otherwise requires, the following terms mean: (1) "Eligible facility", an institution that is operating under a Federalwide Assurance (FWA) for the Protection of Human Subjects under 42 U.S.C. Section 289(a) and 45 CFR Part 46 and that is subject to the FWA laws, regulations, policies, and guidelines, including renewals or updates; (2) "Eligible patient", an individual who meets the following conditions: (a) Has considered all other treatment options currently approved by the United States Food and Drug Administration; (b) Has received a recommendation from his or her physician for an individualized investigational treatment based on analysis of the patient's genomic sequence; human chromosomes; deoxyribonucleic acid; ribonucleic acid; genes; gene products, such as enzymes and other types of proteins; or metabolites; EXPLANATION -- Matter enclosed in bold-faced brackets [thus] in the above bill is not enacted and is intended to be omitted …